• Home
  • About
  • Careers
  • Investors
  • Contact
Menu
  • Home
  • About
  • Careers
  • Investors
  • Contact

Category: Tech

KT 007 Confirm Binding that Affects Two Key Residues in the Catalytic Domain

Up to 12 antibodies or cytokines, of our choice, can be conjugated to our central, propriety, engineered protein-nanoparticle.

Pagliuca Harvard Life Lab
127 Western Ave.
Allston, MA 02134
info@kestreltherpeutics.com

  • About Us
  • Careers
  • Investors
  • Contact
Menu
  • About Us
  • Careers
  • Investors
  • Contact
Linkedin

© 2023 Kestrel Therapeutics. All Rights Reserved.

Biotech website design